Clinical Prediction Rule of Drug Resistant Epilepsy in Children

Pairoj Boonluksiri1, Anannit Visuthibhan2, Kamornwan Katanyuwong3

  • 1Pediatric Neurology Unit, Hatyai Hospital, Songkhla ;

Insights

This study developed a clinical prediction rule (CPR) scoring system for pediatric drug-resistant epilepsy (DRE) using clinical data and basic electroencephalography (EEG). The CPR effectively stratifies children into low, moderate, and high DRE risk categories.

Area of Science:

  • Neurology
  • Pediatrics
  • Clinical Decision-Making

Background:

  • Clinical prediction rules (CPR) aid medical decision-making by integrating patient data into scoring models.
  • Identifying risk factors for drug-resistant epilepsy (DRE) in children is crucial for timely intervention.
  • Basic electroencephalography (EEG) and clinical manifestations are key components in epilepsy assessment.

Purpose of the Study:

  • To develop a clinical prediction scoring system for identifying pediatric drug-resistant epilepsy (DRE).
  • To utilize clinical manifestations and basic electroencephalography (EEG) for DRE risk stratification.
  • To establish a practical tool for assessing DRE risk in children.

Main Methods:

  • A retrospective cohort study involving 308 children diagnosed with epilepsy.
  • Independent determinants of DRE included patient characteristics, clinical manifestations, and EEG findings.
  • Multiple logistic regression analysis was employed to develop the CPR model.

Main Results:

  • The incidence of DRE among the studied children was 42%.
  • Identified risk factors for DRE included age of onset, prior neurological deficits, and abnormal EEG.
  • The developed CPR stratified patients into low (<6), moderate (6-12), and high (>12) risk categories with distinct likelihood ratios.

Conclusions:

  • A CPR with a stratified scoring system effectively categorizes DRE risk in children.
  • Prior global neurological deficits emerged as the most significant risk factor for DRE.
  • This scoring system provides a valuable tool for predicting DRE in pediatric epilepsy patients.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K